Drug Metabolism and Disposition
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.6 | Q2 | 64.3% | 1.054 | Q1 | 85.2% |
| 2024 | 4.0 | Q1 | 77.1% | 1.245 | Q1 | 89.1% |
| 2023 | 4.4 | Q1 | 82.8% | 0.941 | Q1 | 84.0% |
| 2022 | 3.9 | Q2 | 70.1% | 0.851 | Q1 | 82.2% |
| 2021 | 3.6 | Q3 | 61.0% | 0.929 | Q1 | 85.0% |
| 2020 | — | — | 1.025 | Q1 | 85.8% | |
| 2019 | — | — | 1.097 | Q1 | 87.6% | |
| 2018 | — | — | 1.267 | Q1 | 88.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1521-009X
ISSN
0090-9556
region
Northern America
coverage
1973-2026